GME vs VRTX · P/E 16, rev $3.63B vs P/E 30, rev $3.33B
GameStop Corp. (GME) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GME currently screens at market cap $9.78B and trailing P/E 16.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GME and VRTX stock pages for the full models.
Not investment advice.